Melatonin has potent cardioprotective properties. These actions have been attributed to its
free radical scavenging and
anti-oxidant actions, but may also be receptor mediated.
Melatonin also exerts powerful anti-
adrenergic actions based on its effects on contractility of isolated papillary muscles. The aims of this study were to determine whether
melatonin also has anti-
adrenergic effects on the isolated perfused rat heart, to determine the mechanism thereof and to establish whether these actions contribute to protection of the heart during ischaemia/reperfusion. The results showed that
melatonin (50 microM) caused a significant reduction in both
isoproterenol (10(-7) M) and
forskolin (10(-6) M) induced cAMP production and that both these responses were
melatonin receptor dependent, since the blocker,
luzindole (5 x 10(-6) M) abolished this effect.
Nitric oxide (NO), as well as
guanylyl cyclase are involved, as
L-NAME (50 microM), an
NO synthase inhibitor and ODQ (20 microM), a
guanylyl cyclase inhibitor, significantly counteracted the effects of
melatonin.
Protein kinase C (PKC), as indicated by the use of the inhibitor
bisindolylmaleimide (50 microM), also play a role in
melatonin's anti-
adrenergic actions. These actions of
melatonin are involved in its cardioprotection: simultaneous administration of
L-NAME or ODQ with
melatonin, before and after 35 min regional ischaemia, completely abolished its cardioprotection. PKC, on the other hand, had no effect on the
melatonin-induced reduction in
infarct size. Cardioprotection by
melatonin was associated with a significant activation of PKB/Akt and attenuated activation of the pro-apoptotic
kinase, p38MAPK during early reperfusion. In summary, the results show that
melatonin-induced cardioprotection may be receptor dependent, and that its anti-
adrenergic actions, mediated by NOS and
guanylyl cyclase activation, are important contributors.